Is Bupivacaine recalled?
306 FDA recalls mention Bupivacaine. The most recent are listed below.
Recalls are matched by product description. A recall usually affects specific lots, not every package of Bupivacaine.
Class II · Moderate risk Terminated Sep 16, 2016
Reason Lack of Assurance of Sterility and Subpotent Drug: defect in glass vial prevented stopper from forming a seal allowing water to ingress and dilute…
Class I · High risk Ongoing Aug 4, 2016
Reason Presence of particulate matter: Confirmed customer report for the presence of particulate matter within a single vial.
Class II · Moderate risk Terminated May 5, 2016
Reason Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.
Class II · Moderate risk Terminated May 5, 2016
Reason Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.
Class II · Moderate risk Terminated May 5, 2016
Reason Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.
Class II · Moderate risk Terminated May 5, 2016
Reason Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.
Class II · Moderate risk Terminated May 5, 2016
Reason Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.
Class II · Moderate risk Terminated May 5, 2016
Reason Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.
Class II · Moderate risk Terminated May 5, 2016
Reason Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.
Class II · Moderate risk Terminated May 5, 2016
Reason Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.
Class II · Moderate risk Terminated May 5, 2016
Reason Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.
Class II · Moderate risk Terminated May 5, 2016
Reason Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.
Class II · Moderate risk Terminated May 5, 2016
Reason Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.
Class II · Moderate risk Terminated May 5, 2016
Reason Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.
Class II · Moderate risk Terminated May 5, 2016
Reason Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.
Class II · Moderate risk Terminated May 5, 2016
Reason Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.
Class II · Moderate risk Terminated May 5, 2016
Reason Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.
Class II · Moderate risk Terminated May 5, 2016
Reason Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.
Class II · Moderate risk Terminated May 5, 2016
Reason Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.
Class II · Moderate risk Terminated May 5, 2016
Reason Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.
Class II · Moderate risk Terminated May 5, 2016
Reason Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.
Class II · Moderate risk Terminated May 5, 2016
Reason Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.
Class II · Moderate risk Terminated May 5, 2016
Reason Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.
Class II · Moderate risk Terminated May 5, 2016
Reason Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.
Class II · Moderate risk Terminated May 5, 2016
Reason Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.